RGLS
ProShare Advisors’s Regulus Therapeutics RGLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,671
| Closed | -$23.9K | – | 2168 |
|
|
2025
Q1 | $23.9K | Sell |
13,671
-4,114
| -23% | -$7.2K | ﹤0.01% | 2026 |
|
|
2024
Q4 | $28.1K | Buy |
17,785
+5,853
| +49% | +$9.25K | ﹤0.01% | 2238 |
|
|
2024
Q3 | $18.7K | Buy |
+11,932
| New | +$18.7K | ﹤0.01% | 2046 |
|
|
2016
Q4 | – | Sell |
-37,144
| Closed | -$123K | – | 1751 |
|
|
2016
Q3 | $123K | Sell |
37,144
-6,893
| -16% | -$22.8K | ﹤0.01% | 1402 |
|
|
2016
Q2 | $127K | Buy |
44,037
+1,561
| +4% | +$4.5K | ﹤0.01% | 1496 |
|
|
2016
Q1 | $294K | Sell |
42,476
-3,736
| -8% | -$25.9K | ﹤0.01% | 1216 |
|
|
2015
Q4 | $403K | Buy |
46,212
+3,910
| +9% | +$34.1K | ﹤0.01% | 1141 |
|
|
2015
Q3 | $277K | Sell |
42,302
-2,031
| -5% | -$13.3K | ﹤0.01% | 1178 |
|
|
2015
Q2 | $486K | Buy |
44,333
+662
| +2% | +$7.26K | 0.01% | 1109 |
|
|
2015
Q1 | $740K | Buy |
43,671
+8,177
| +23% | +$139K | 0.01% | 995 |
|
|
2014
Q4 | $569K | Buy |
35,494
+7,685
| +28% | +$123K | 0.01% | 1132 |
|
|
2014
Q3 | $190K | Sell |
27,809
-5,200
| -16% | -$35.5K | ﹤0.01% | 1994 |
|
|
2014
Q2 | $265K | Sell |
33,009
-10,385
| -24% | -$83.4K | ﹤0.01% | 1994 |
|
|
2014
Q1 | $391K | Buy |
43,394
+24,323
| +128% | +$219K | ﹤0.01% | 2052 |
|
|
2013
Q4 | $141K | Buy |
+19,071
| New | +$141K | ﹤0.01% | 1281 |
|